Search
for
Sort by
Research 841–870 of 1000+
- Medicinal uses, pharmacological activities, phytochemistry, and the molecular mechanisms of Punica granatum L. (pomegranate) plant extracts: A review
- Research and development of Chinese anti-COVID-19 drugs
- A concomitant diagnosis of COVID‐19 infection and systemic lupus erythematosus complicated by a macrophage activation syndrome: A new case report
- Solid-State Fermentation for the Recovery of Phenolic Compounds from Agro-Wastes
- Effects of 5‐alpha reductase inhibitors on lung function: A reason for discontinuation duringCOVID‐19 pandemic?
- Updated Integrated Safety Analysis of Ritlecitinib Up to ~5 Years in Patients With Alopecia Areata From the ALLEGRO Clinical Trial Program
- A Systematic Scoping Review and Conceptual Analysis of New-Onset Fibromyalgia Manifestations After Non-Hospitalized COVID-19: Empirics, Definitions, Methodologies, Pathophysiology, Mapping of Literature, and Knowledge Gaps
- 220 Dynamic and spatial transcriptional responses in COVID-19-related chilblains
- COVID-19: How Effective Are the Repurposed Drugs and Novel Agents in Treating the Infection?
- A systematic review on Drug Re-profiling/Re-Purposing
- Reporte de caso: Presentación clínica e importancia de coinfecciones durante pandemia por COVID-19 en pacientes con neoplasias malignas
- Treatment of Alopecia Areata with Oral JAK Inhibitor : Focusing on Clinical Outcomes with Baricitinib
- Resolution of advanced conjunctival squamous cell carcinoma with cemiplimab immunotherapy, IFNα-2b, and retinoic acid treatment over 2 years of follow-up
- Correlation between Androgenetic Alopecia and Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant Infection in China
- Serum vitamin D, ferritin, and TSH in patients with telogen effluvium: a retrospective epidemiological study
- Long-Term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-Year Results from the ALLEGRO Phase 2b/3 and ALLEGRO-LT Phase 3 Clinical Studies
- Acute Telogen Effluvium Related To COVID-19 Infection: A Review
- Epidermal growth factor receptor mutant T790M-L858R-V948R inhibitor from Calophyllum inophyllum L. leaf as potential non-small cell lung cancer drugs
- Does topical minoxidil at concentrations higher than 5% provide additional clinical benefit?
- Alopecia and grey hair are associated with COVID‐19 Severity
- Possibilities for correcting diffuse alopecia associated with prior coronavirus infection (COVID-19)
- Ritlecitinib in severe alopecia areata: a profile of its use
- ANAIS DO I CONGRESSO MÉDICO DE FORMOSA - COMEF
- THE COVID- 19 VACCINATION: AUTOIMMUNE PHENOMENON ALOPECIA AREATA
- Five cluster classifications of long COVID and their background factors: A cross-sectional study in Japan
- Neem (Azadirachta indica): A Panacea of all Diseases
- Hubungan Antara Telogen Effluvium Dengan Kejadian Paska Infeksi Covid-19 Di Klinik Sukma Periode Januari 2023-Februari 2023
- A prospective cross-sectional study on post COVID-19 hair loss at a tertiary care hospital
- Hair disorders associated with post-COVID-19 infection in females: a cross-sectional study
- Evaluation of patients with telogen effluvium during the pandemic: May the monocytes be responsible for post COVID‐19 telogen effluvium?